Clinical Trials Browser

Phase 3 × pegvisomant × Clear all

NCT00017927 2008-03-04

A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome

Phase 3 Completed

Acromegaly, Adenoma, Fibrous Dysplasia, Polyostotic, Hyperplasia